In this episode, Molly Gamble, Vice President of Editorial at Becker’s Healthcare discusses announced healthcare executive moves & exits in 2024, Intermountain ending their precision medicine program and healthcare hopeful 23andMe's valuation down 98%.
Molly Gamble, Vice President of Editorial at Becker’s Healthcare
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.
Subscribe to Our Podcasts
